High-Dose, Unlabeled, Nonspecific Antibody Pretreatment: Influence on Specific Antibody Localization to Human Melanoma Xenografts

Cancer Immunology, Immunotherapy - Germany
doi 10.1007/bf00205633
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Nature

Related search

Grp94-Specific Monoclonal Antibody to Counteract BRAF Inhibitor Resistance in BRAFV600E Melanoma

Journal of Translational Medicine
BiochemistryMedicineGeneticsMolecular Biology
2015English

Influenza Virus–Specific Human Antibody Repertoire Studies

Journal of Immunology
AllergyImmunology
2019English

Tropomyosin Antibody: The Specific Localization of Tropomyosin in Nonmuscle Cells

Journal of Cell Biology
MedicineCell Biology
1975English

Doxorubicin Conjugated With a Monoclonal Antibody Directed to a Human Melanoma-Associated Proteoglycan Suppresses the Growth of Established Tumor Xenografts in Nude Mice.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1988English

PET Imaging of Prostate Cancer Xenografts With a Highly Specific Antibody Against the Prostate-Specific Membrane Antigen

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2009English

Antibody to Fungal Melanin Part of Promising Melanoma Treatment

Microbe
Microbiology
2012English

A Monoclonal Antibody Specific to Surface Antigen on Candida Krusei

Clinical Diagnostic Laboratory Immunology
1998English

Perinuclear Anti Neutrophil Cytoplasmic Antibody Vasculitis With Nonspecific Muscle Pain

International Journal of Research in Medical Sciences
2020English

Antibody Response to Melanoma Helper-Peptide Vaccine Correlates With Survival

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2013English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy